Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic modulation of motility.

R W McCallum1

  • 1Department of Gastroenterology and Hepatology, Center for GI Motility Disorders, University of Kansas Medical Center, Kansas City 66160, USA. rmccalu@kumc.edu

The Yale Journal of Biology and Medicine
|April 26, 2000
PubMed
Summary

Gastroesophageal reflux disease (GERD) is a motility disorder. Prokinetic agents improve upper gastrointestinal motility, addressing underlying causes of GERD and reflux esophagitis for effective management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of needleless transcutaneous electroacupuncture in synchronization with breathing for symptomatic idiopathic gastroparesis: A blinded and controlled acute treatment trial.

Neurogastroenterology and motility·2018
Same author

Does a glucose-based hydrogen and methane breath test detect bacterial overgrowth in the jejunum?

Neurogastroenterology and motility·2018
Same author

Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.

Neurogastroenterology and motility·2017
Same author

Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis.

Neurogastroenterology and motility·2017
Same author

Diabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrum.

Neurogastroenterology and motility·2017
Same author

Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing.

Neurogastroenterology and motility·2016

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Motility Disorders

Background:

  • Gastroesophageal reflux disease (GERD) is often viewed as a motility disorder.
  • Acid suppression is effective but doesn't resolve underlying reflux causes like acid, pepsin, and bile.
  • Underlying neuromuscular abnormalities contribute to GERD's multifactorial nature.

Purpose of the Study:

  • To discuss the rationale for pharmacologic modulation in GERD treatment.
  • To review current concepts and theories on GERD's neuromuscular mechanisms.
  • To emphasize tailoring medical therapy for GERD.

Main Methods:

  • Review of current concepts and postulated theories on neuromuscular abnormalities in GERD.
  • Discussion of the role of prokinetic agents in managing reflux esophagitis.
  • Exploration of multifactorial aspects of GERD.

Main Results:

  • Pharmacologic modulation, particularly with prokinetic agents, addresses upper gastrointestinal motility disturbances.
  • Prokinetic agents play a significant role in both short- and long-term GERD management.
  • Understanding neuromuscular mechanisms supports tailored therapeutic approaches.

Conclusions:

  • GERD's etiology involves motility disturbances, making prokinetic agents a key therapeutic option.
  • Pharmacologic modulation targeting neuromuscular function offers a comprehensive approach to GERD.
  • Personalized medical therapy based on GERD's multifactorial aspects is crucial.

Related Experiment Videos